A new study led by researchers at Boston Children’s Hospital aims to determine whether monoclonal antibody Xolair (omalizumab) can stop or lessen the progression of asthma in high-risk children.
As the affordable housing crisis worsens across the country, research shows that ensuring housing stability has a big impact on health outcomes.
As a new longitudinal study shows a definitive connection between the Epstein-Barr virus and multiple sclerosis, research turns to vaccines, new treatments — and the further roots of what causes the disease.
New research found no difference in rates of preterm births after adjusting for other risk factors.
Researchers at St. Jude Children’s Research Hospital found that adding a novel anti-disialoganglioside GD2 (anti-GD2) monoclonal antibody to the standard therapy for children newly diagnosed with high-risk neuroblastoma significantly enhanced response to treatment and improved survival. Their findings could be transformative if additional studies can produce similar results.
New retrospective research indicates depression management may lower mortality rates among those with MS.
New data indicates patients report myocarditis at higher rates after the use of immune checkpoint inhibitors during cancer treatment.
Evidence indicates the strongest connection between the vaccination and myocarditis is among males ages 16 to 29.
The link between obesity and cardiovascular health is well established. Until recent years, however, it was unclear whether bariatric surgery could improve morbidity and mortality among obese individuals who had already experienced significant cardiovascular events.
Microbubbles May Boost Response to Transarterial Radioembolization for the Most Common Form of Liver Cancer
In a first-of-its-kind clinical trial, researchers at Thomas Jefferson University demonstrated the safety of combining ultrasound-triggered microbubble destruction and transarterial radioembolization (TARE) to treat patients with hepatocellular carcinoma — and found that combining the therapies was nearly twice as effective as TARE alone.
- 1 of 14
- next ›